Abstract
Background
Intrauterine adhesions (IUA) are a challenging clinical problem in reproductive infertility. The most common causes are intrauterine surgery and abortions. We aimed to investigate whether early second-look office hysteroscopy can prevent IUA.
Methods
A single-center, prospective, two-armed, randomized controlled trial was designed to explore the efficacy of early office hysteroscopy after first-trimester induced abortion (suction dilatation and curettage [D&C]) and to further analyze fertility outcomes. Women aged 20–45 years undergoing suction D&C and desiring to conceive were recruited. Between October 2019 and September 2022, 66 women were enrolled, of whom 33 were allocated to group A (early hysteroscopy intervention). The women in intervention group A were planned to receive 2 times of hysteroscopies (early and late). In group B, women only underwent late (6 months post suction D&C) hysteroscopy.
Results
The primary outcome was the IUA rate assessed using office hysteroscopy 6 months after artificial abortion. Secondary outcomes included menstrual amount/durations and fertility outcomes. In intervention group A, 31 women underwent the first hysteroscopy examination, and 15 completed the second. In group B (late hysteroscopy intervention, 33 patients), 16 completed the hysteroscopic exam 6 months after an artificial abortion. Twenty-one women did not receive late hysteroscopy due to pregnancy. The IUA rate was 16.1% (5/31) at the first hysteroscopy in group A, and no IUA was detected during late hysteroscopy. Neither group showed statistically significant differences in the follow-up pregnancy and live birth rates.
Conclusions
Early hysteroscopy following suction D&C can detect intrauterine lesions. IUA detected early by hysteroscopy can disappear on late examination and become insignificant for future pregnancies. Notably, the pregnancy outcomes showed a favorable trend in the early hysteroscopy group, but there were no statistically significant differences.
Trial registration
ClinicalTrials.gov, ID: NCT04166500. Registered on 2019-11-10. https://clinicaltrials.gov/ct2/show/NCT04166500.
Background
Intrauterine adhesions (IUA) are a challenging clinical problem in reproductive infertility [1]. They are typically caused by trauma to the endometrial basal layer during curettage, endometritis, and hysteroscopic myomectomy [2, 3]. Therefore, hysteroscopy is presently the main treatment for IUA [3, 4].
The IUA rate after miscarriages has been reported to be 6–20% [5,6,7,8,9], and the probability of develo** IUAs after induced abortion ranges from 15 to 50% [6, 7, 10]. Previous studies have reported IUA rates; however, few have reported the impact of IUA on reproductive outcomes [6]. Dilatation and curettage (D&C) is a known risk factor for the development of IUA [5, 6], especially with profound negative suction pressure, or sharp, blind, or multiple curettages [5]. Therefore, increased awareness and recognition of IUA are crucial for early diagnosis and avoiding fibrotic scar formation [11]. The filmy adhesion bands in the early stage can be broken up by gently manipulating the hysteroscope with a distension pressure of 50–100 mmHg [4, 12]. However, once late adhesions form, harsh surgical steps are required for adhesiolysis, which are often accompanied by the risk of uterine perforation and further re-adhesion.
In a study [4] following hysteroscopic myomectomy for 1–3 months, IUA prevalence was 78% in the group without early lysis, and 0% in the early lysis group. The IUA rate was also related to myoma location and number. In addition, they [4] demonstrated that office hysteroscopy within 2 weeks of transcervical resection (TCR) is an efficient procedure for separating newly formed IUA. Previous studies [5, 7, 8] have advocated that post-abortion hysteroscopy is valuable for diagnosing acquired and congenital intrauterine pathologies, especially for women experiencing recurrent abortions.
No randomized control trials (RCTs) have analyzed the early hysteroscopic effect in preventing IUA, or fertility outcomes after IUA. We hypothesized that early second-look office hysteroscopy following induced abortion (suction D&C) with appropriate normal saline flushing might detect lesions earlier and further prevent IUA. The follicular phase of the first menstrual period after miscarriage was selected as a suitable time for early diagnosis of adhesions. In the present study, women with a further desire for conception were allocated to either early (first follicular phase of the last menstrual period following D&C) or late (6 months following D&C) hysteroscopy, and the effects were evaluated.
Methods
Participants
This is a single-center, prospective, two-armed, randomized controlled trial. Women were eligible to participate if they were 20–45 years of age, had a first-trimester induced abortion procedure in the previous month, and desired to conceive further. The participants were recruited from a medical center. Women who have had medical abortions, a known or possible increased risk of active pelvic infection (lower abdominal pain with tuboovarian complex mass or increased vaginal discharges), a history of more than three suction D&Cs, previous intrauterine myomectomy, previously confirmed intrauterine adhesions, or poor comprehension of spoken Mandarin were not eligible and excluded from this trial. If the patients became pregnant after enrollment, they were withdrawn from the trial after recording their fertility outcomes. If the rate of IUA in both groups is very low or if any group is found to have an inferior pregnancy outcome, the study will be considered stopped.
Trial registration
ClinicalTrials.gov, ID: NCT04166500. Registered on 2019-11-10. https://clinicaltrials.gov/ct2/show/NCT04166500.
Randomization and blinding
After obtaining all baseline characteristics and evaluations, patients were randomly assigned to either the early hysteroscopy examination group (group A: women who underwent office hysteroscopy at the first follicular phase of the last menstrual period, and 6 months after D&C) or the late group (group B: women who underwent office hysteroscopy at 6 months after D&C) in a 1:1 ratio, in permuted blocks of four. A commissioner of the statistics center was responsible for generating block sizes and random codes using a computer-generated random-allocation sequence, which was concealed from the recruiting study assistant [13]. Given the nature of the intervention, it was impossible to blind the investigators or participants to group allocation.
Sample size calculation
According to the literature, the probability of develo** intrauterine adhesions after induced abortion ranges from 15 to 50% [6, 7, 10]. Considering the more severe cases of IUA, assuming a probability of 20% for the control group without any intervention after induced abortion (p0) and an expected improvement of δ = 15% (effect size = 0.48, moderate effect size), with a type I error rate (α) of 0.05 and a statistical power (1-β) of 0.8, a total of 60 participants are required per group based on the Z-test. Considering a 20% dropout rate, each group needs to include 75 participants, resulting in 150 participants in total.
Induced abortion procedure: suction dilatation and curettage
The indications for choosing surgical abortion are as follows: (i) Fear of incomplete abortion from medical abortion. (ii) The patient wants to have the gestational tissue collected for chromosome study. (iii) Fear of heavy bleeding or uncertain cram** pain at home. The included criteria of suction D&C in this study were missed abortions before 13 gestational weeks. The standard procedure has been previously reported [14]. There was no preoperative misoprostol used. The patients who underwent D&C were anesthetized and placed in the lithotomy position. During the procedure, transabdominal ultrasonography was guided through a distended bladder to monitor the uterine axis and avoid unexpected uterine perforations and drastic blind curettage. After adequate Hegar dilation, the placental forceps and suction curette were gently applied to extract the gestational tissues. Intraoperative oxytocin was infused for better uterine contraction. A clear endometrial line and cavity were observed on ultrasound monitoring. Postoperative antibiotic prophylaxis was used.
Hysteroscopy examination procedure
As per the study design, women allocated to the early group received two hysteroscopies (one at the first follicular phase of the menstrual cycle and the other at 6 months following D&C), and those in the late group received one (6 months following D&C). Hysteroscopy at 6 months was deferred in patients who got pregnant during the study or withdrew from the trial. All hysteroscopies were performed by the first and corresponding authors in the early proliferative phase using a Hysterovideoscope HYF (Olympus Optical Co., Tokyo, Japan). Office hysteroscopy was conducted using a flexible hysteroscope with a 3.8 mm diameter without mechanical or drug-induced cervical dilatation [15]. Neither anesthesia nor tenaculum usage was required. After sterilization, the hysteroscope was introduced, and saline solution (0.9% NaCl) with a distending media flow of 50–100 mmHg [16] was delivered into the uterine cavity from 60 cm above the patient. If a newly formed IUA was found, the doctor used the tip of the hysteroscope and the water flow force to separate the adhesion [4].
Outcomes
The primary outcome was the IUA rate assessed using office hysteroscopy 6 months after D&C. IUA was observed and classified according to the American Fertility Society classification, with a mildest score of 1 to the most severe score of 12 [17].
Secondary outcomes included IUA score, menstrual amount (using pictorial blood loss assessment charts [PACs]) [18, 19], self-reported by patients and questionnaires), and fertility outcomes (pregnancy rates, abortion rates, ongoing pregnancy rates, and live birth rates). Ongoing pregnancy was defined as a viable pregnancy beyond 12 weeks of gestation. Abortion was defined as a pregnancy that terminated spontaneously before 12 weeks of gestation. Live birth was defined as the delivery of a viable fetus beyond 23 weeks of gestation [20].
Statistical analysis
Continuous data are presented as mean ± standard deviation (SD). Mann–Whitney U tests were used to compare continuous data. Categorical variables, reported as proportions, were compared using the chi-squared test or Fisher’s exact test, as appropriate. All tests of significance were two-tailed, with p < 0.05 defined as being statistically significant. All statistical analyses were performed using SPSS for Windows, version 18.
Results
A flowchart of the study is shown in Fig. 1. During the 3 years of study period, we enrolled 71 eligible participants from October 2019 to September 2022. Five women were excluded because they withdrew consent or were found to be ineligible after randomization. Sixty-six women were randomly allocated to receive either early (n = 33) or late hysteroscopy (n = 33). Two women in group A lost follow-up before 1st hysteroscopy exam. The follow-up rates were 81.8% (27/33) in the early intervention group and 75.8% (25/33) in the late group. The mean age was 37.6 ± 3.0 years in group A and 37.0 ± 4.8 years in group B (p = 0.57). Other baseline parameters, including BMI, and number of abortion histories, were comparable between the two groups (Table 1).
No adverse events were observed during the trial period; no pelvic infections, uterine perforations, or significant vaginal bleeding were encountered.
Primary outcome
In group A, 31 women underwent their first hysteroscopy, and 16.1% (5 of 31 cases) had mild-to-moderate IUA (extending < 1/3 uterine cavity; AFS scores were 2, 2, 2, 5, and 3). These five cases had all undergone induced abortion for the first time.
After 6 months of follow-up, 15 women in group A and 16 in group B were eligible for late hysteroscopic examination. The IUA rate was 0% in both groups (Table 2).
Data on the primary outcome were unavailable for 18 women in the early hysteroscopy group and 17 in the late hysteroscopy group, because some became pregnant, some were unwilling to return to the hospital for examination, and others were lost to follow-up.
Secondary outcomes
The pregnancy rate was 55.6% (15/27) in the early intervention group and 40.0% (10/25) in the late intervention group (p = 0.26). The live birth, ongoing pregnancy, and abortion rates in group A were 60.0% (9/15), 60.0% (9/15), and 6.7% (1/15), respectively. The live birth, ongoing pregnancy, and abortion rates in group B were 30% (3/10), 50% (5/10), and 20% (2/10), respectively. Fertility and other secondary outcomes are summarized in Table 3. There were no significant differences between the two groups.
Discussion
This novel prospective RCT design appears to provide the first documentation of the timing of office hysteroscopy in preventing IUA attributable to suction D&C. IUA detected early by hysteroscopy can disappear on late examination and become insignificant for future pregnancies. Regular early hysteroscopic examination following meticulous and sonography-guided D&C may not be necessary.
There are many protocols for non-surgical termination of pregnancy, like mifepristone and misoprostol [21, 22]. For the prevention of surgery and its complications, medical methods should be offered to the patient, and the final decision should be made with input from both sides. Blind and sharp curettages induce scar formation [5, 23]. Therefore, intraoperative transabdominal ultrasound monitoring is routinely performed at our hospital during suction D&C to ensure a clear endometrium and avoid unnecessary curettage [14]. In the present study, the IUAs formed were mild-to-moderate, extending to less than a third of the uterine cavity. This may explain why IUAs became insignificant at the late follow-up. According to Gilman et al., the estimated incidence of IUA following office hysteroscopy 2–4 months after a miscarriage was 6.3% [5]. The hysteroscopy evaluation period was similar to that of our early group, in which the IUA rate was 16.1%. Our study found that IUA detected early in hysteroscopy would disappear on the late examination and become insignificant for future pregnancies. Two women had mild IUA on early hysteroscopy and became naturally pregnant within 6 months. The other three women with IUA showed resolution on the second hysteroscopy. Endometrial repair and remodeling during the menstrual cycle [23] (breakdown bleeding and re-epithelialization) may facilitate lesion resorption.
In this study, the signs and symptoms of IUA (n = 5) identified during the first hysteroscopy in group A were nonspecific. They did not manifest typical IUA clinical features [5], possibly because of mild uterine cavity involvement. The mean age was 35.6 years, there was a history of one abortion, the average menstrual blood was not decreased (the average points on Pictorial blood loss assessment charts was 178), and the menstrual duration was typically 7 days. The mean endometrial thickness was 0.88 cm with non-specific morphology. From this perspective, office hysteroscopy may be the examination of choice when IUA is suspected [24]. Figure 2 shows the transvaginal ultrasonography and hysteroscopy findings of IUA in group A.
The transvaginal ultrasound and hysteroscopy finding with IUA (a&b) and RPOC (c&d). (a), A 34-year-old woman with G1P0AA1. The endometrial thickness was 0.79 cm. (b), The hysteroscopic image shows a dense IUA (asterisk) near the right ostium. The patient became pregnant during the follow-up period and did not receive a second hysteroscopy. (c), A 38-year-old woman with G1P0AA1. The endometrial thickness was 0.79 cm. (d), Hysteroscopy image revealing RPOC over the posterior cavity wall
IUA, intrauterine adhesion; RPOC, retained products of conception
Retained products of conception (RPOC) after pregnancy termination are not uncommon [25,26,27]. The presenting signs and symptoms include irregular vaginal bleeding and abnormal endometrial morphology on ultrasonography [25]. In the study, eight (8/31 = 25.8%) women were diagnosed with RPOC during early hysteroscopy, and six of them subsequently achieved pregnancy. In the late (6 months later) hysteroscopy, no women in group A and one in group B had RPOC. According to Raz N et al. [26], the see-and-treat approach during office hysteroscopy is as effective as operative hysteroscopy for RPOC smaller than 2 cm. Most RPOC after first-trimester abortion could be expectant management if there is no massive bleeding or hypervascularity [28]. The actual impact of RPOC following sonography-guided D&C is unclear. Whether early hysteroscopy to detect the lesion earlier is beneficial requires further investigation.
The pregnancy rate was higher in the early intervention group, although it was not significantly different from that in group B (Table 3). During early hysteroscopy, intrauterine lesions were found in 17 out of 31 cases, including retained products of conception (n = 8), intrauterine adhesions (n = 5), polyps (n = 1), submucosal myoma (n = 1), Mullerian duct anomaly (n = 1), and cesarean scar defect (n = 1). This would help us better understand the causes of miscarriage in patients, which would further facilitate subsequent pregnancies. Besides, during hysteroscopy, cervical dilation may correct stenosis, and uterine distention fluid flushes the uterine cavity while stimulating certain estrogen receptor factor expression [29, 30]. Whether early hysteroscopy enhances fertility requires further investigation.
The strengths of this study are its prospective design, homogeneous patient selection, and fertility outcome follow-up. Due to the extraordinary circumstances, patient recruitment and follow-up for this trial were significantly limited. First, we failed to recruit sufficient patients within the contract period, partially due to the coronavirus disease pandemic. Second, we were unable to retain patients due to some getting pregnant and cannot receive hysteroscopies. However, because very few IUAs were detected 6 months after suction D&C in this study, we decided to close the study, in compliance with the contract. Third, we excluded women with documented IUA, more than three abortions, and a history of TCR myomectomy. Patients who underwent spontaneous and/or medical abortions were also excluded. Fourth, hyaluronic gel or intrauterine balloon insertion may be an option for IUA prevention [31, 32]. However, we didn’t include these cohorts in this trial. Further studies may explore the role of hysteroscopy/ hyaluronic gel after multiple suction D&Cs and/or medical abortion. This preliminary report could be an impetus for others to attempt and verify it.
Conclusions
This study suggests that early office hysteroscopy following well-monitored suction D&C with intraoperative sonography may not be necessary. Early hysteroscopy allowed early detection of intrauterine lesions. It is worth noting that the pregnancy outcomes had a favorable trend in the early hysteroscopy group but no statistically significant differences.
Data availability
All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.
Abbreviations
- IUA:
-
Intrauterine adhesions
- D&C:
-
Dilatation and curettage
- TCR:
-
Transcervical resection
- PACs:
-
Pictorial blood loss assessment charts
- RPOC:
-
Retained products of conception
References
Di Guardo F, Della Corte L, Vilos GA, et al. Evaluation and treatment of infertile women with Asherman syndrome: an updated review focusing on the role of hysteroscopy. Reprod Biomed Online. 2020;41(1):55–61.
Yen CF, Chou HH, Wu HM, Lee CL, Chang TC. Effectiveness and appropriateness in the application of office hysteroscopy. J Formos Med Assoc. 2019;118(11):1480–7.
Huang XW, Lin MM, Zhao HQ, et al. A prospective randomized controlled trial comparing two different treatments of intrauterine adhesions. Reprod Biomed Online. 2020;40(6):835–41.
Yang JH, Chen MJ, Wu MY, Chao KH, Ho HN, Yang YS. Office hysteroscopic early lysis of intrauterine adhesion after transcervical resection of multiple apposing submucous myomas. Fertil Steril. 2008;89(5):1254–9.
Gilman AR, Dewar KM, Rhone SA, Fluker MR. Intrauterine adhesions following miscarriage: look and learn. J Obstet Gynaecol Can. 2016;38(5):453–7.
Hooker AB, Lemmers M, Thurkow AL, et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors, and long-term reproductive outcome. Hum Reprod Update. 2014;20(2):262–78.
Friedler S, Margalioth EJ, Kafka I, Yaffe H. Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy–a prospective study. Hum Reprod. 1993;8(3):442–4.
Römer T. Post-abortion-hysteroscopy–a method for early diagnosis of congenital and acquired intrauterine causes of abortions. Eur J Obstet Gynecol Reprod Biol. 1994;57(3):171–3.
Kim MJ, Lee Y, Lee C, et al. Accuracy of three dimensional ultrasound and treatment outcomes of intrauterine adhesion in infertile women. Taiwan J Obstet Gynecol. 2015;54(6):737–41.
Hooker A, Fraenk D, Brolmann H, Huirne J. Prevalence of intrauterine adhesions after termination of pregnancy: a systematic review. Eur J Contracept Reproductive Health care: Official J Eur Soc Contracept. 2016;21(4):329–35.
Salazar CA, Isaacson K, Morris S. A comprehensive review of Asherman’s syndrome: causes, symptoms and treatment options. Curr Opin Obstet Gynecol. 2017;29(4):249–56.
Shokeir TA, Fawzy M, Tatongy M. The nature of intrauterine adhesions following reproductive hysteroscopic surgery as determined by early and late follow-up hysteroscopy: clinical implications. Arch Gynecol Obstet. 2008;277(5):423–7.
Morielli AR, Usmani N, Boule NG, et al. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial. Trials. 2018;19(1):35.
Cheng LY, Wang CB, Chu LC, Tseng CW, Kung FT. Outcomes of primary surgical evacuation during the first trimester in different types of implantation in women with cesarean scar pregnancy. Fertil Steril. 2014;102(4):1085–90. e2.
Ou YC, Huang KH, Lan KC. Hysteroscopic cervical features associated with difficult embryo transfer in unselected patients undergoing in vitro fertilization. Biomed J. 2022;45(3):557–64.
Chen YY, Tsai CC, Kung FT, Lan KC, Ou YC. Association between hysteroscopic findings of previous cesarean delivery scar defects and abnormal uterine bleeding. Taiwan J Obstet Gynecol. 2019;58(4):541–4.
The American Fertility. Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril. 1988;49(6):944–55.
Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97(8):734–9.
Warrilow G, Kirkham C, Ismail KM, Wyatt K, Dimmock P, O’Brien S. Quantification of menstrual blood loss. Obstetrician Gynaecologist. 2004;6(2):88–92.
Tsai NC, Su YT, Lin YJ, et al. Developmental potential of surplus morulas with delayed and/or incomplete compaction after freezing-thawing procedures. Reprod Biol Endocrinol. 2019;17(1):87.
Kapp N, Lohr PA. Modern methods to induce abortion: safety, efficacy and choice. Best Pract Res Clin Obstet Gynaecol. 2020;63:37–44.
Kelesidou V, Tsakiridis I, Virgiliou A, et al. Combination of Mifepristone and Misoprostol for First-Trimester Medical Abortion: a Comprehensive Review of the literature. Obstet Gynecol Surv. 2024;79(1):54–63.
Lee WL, Liu CH, Cheng M, Chang WH, Liu WM, Wang PH. Focus on the Primary Prevention of Intrauterine Adhesions: current Concept and Vision. Int J Mol Sci. 2021;22(10).
Deans R, Abbott J. Review of Intrauterine adhesions. J Minim Invasive Gynecol. 2010;17(5):555–69.
Ben-Ami I, Ofir T, Melcer Y et al. Infertility following retained products of conception: is it the surgical procedure or the presence of trophoblastic tissue? European journal of obstetrics, gynecology, and reproductive biology. 2014;182:132–5.
Raz N, Sigal E, Gonzalez Arjona F, et al. See-and-treat in-office hysteroscopy versus operative hysteroscopy for the treatment of retained products of conception: a retrospective study. J Obstet Gynaecol Res. 2022;48(9):2459–65.
Han L, Shi G, Zheng A, Ruan J. Hysteroscopy for retained products of conception: a single-institution experience. BMC Womens Health. 2023;23(1):25.
Wada Y, Takahashi H, Suzuki H, et al. Expectant management of retained products of conception following abortion: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2021;260:1–5.
Makrakis E, Pantos K. The outcomes of hysteroscopy in women with implantation failures after in-vitro fertilization: findings and effect on subsequent pregnancy rates. Curr Opin Obstet Gynecol. 2010;22(4):339–43.
Gao M, Sun Y, **e H, Fang S, Zhao X. Hysteroscopy prior to repeat embryo transfer may improve pregnancy outcomes for asymptomatic women with repeated implantation failure. J Obstet Gynaecol Res. 2015;41(10):1569–76.
Sroussi J, Bourret A, Pourcelot AG, et al. Does hyaluronic acid gel reduce intrauterine adhesions after dilation and curettage in women with miscarriage? A multicentric randomized controlled trial (HYFACO Study). Am J Obstet Gynecol. 2022;227(4):597.e1-.e8.
Zhang H, Shao L, Wang L, et al. Chitosan combined with intrauterine device prevents intrauterine adhesions after hysteroscopic adhesiolysis: a target trial emulation study. J Obstet Gynaecol Res. 2023;49(6):1571–8.
Acknowledgements
We thank the Chang Gung Medical Foundation and Kaohsiung Chang Gung Memorial Hospital Clinical Trial Center for their excellent technical support. We thank the staff of the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital for their statistical support. We thank the OB-GYN doctors at Kaohsiung Chang Gung Memorial Hospital for their case referrals. In addition, we acknowledge the research assistants Yun-Chiao Chang and Pei-Ling Weng for their assistance with patient registration and data collection.
Funding
This study was supported by CMRPG8J1131-2 from the Chang Gung Memorial Hospital. The funder had no role in the study design, data collection, analysis, publication decision, or manuscript preparation.
Author information
Authors and Affiliations
Contributions
Conception and design of study: KCL; analysis of data and writing of the manuscript: NCT, KCL; critical revision of the article for intellectual content: NCT, YYH, YTS, YJL, FTK, PHC, KCL. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was conducted in strict accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Chang Gung Memorial Hospital (Ref. Nos. 201900964A3, 201900964A3C601, and 201900964A3C501). All participants gave written informed consent before enrollment.
Consent for publication
This manuscript does not report personal data, such as individual details, so consent for publication is not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Tsai, NC., Hsiao, YY., Su, YT. et al. The efficacy of early office hysteroscopy in preventing intrauterine adhesions after abortion: a randomized controlled trial. BMC Women's Health 24, 400 (2024). https://doi.org/10.1186/s12905-024-03247-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12905-024-03247-0